Raymond DuBois to Pyrazoles
This is a "connection" page, showing publications Raymond DuBois has written about Pyrazoles.
Connection Strength
1.187
-
New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs. Cancer Prev Res (Phila). 2009 Apr; 2(4):285-7.
Score: 0.298
-
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
Score: 0.268
-
Cyclooxygenase-2 selective inhibitors and prostate cancer: what is the clinical benefit? J Clin Oncol. 2006 Jun 20; 24(18):2691-3.
Score: 0.245
-
The COX-2 story: is any drug completely "safe?". Gastroenterology. 2006 Jan; 130(1):6.
Score: 0.238
-
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005 May 01; 65(9):3735-44.
Score: 0.057
-
COX-2 inhibition and colorectal cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):12-21.
Score: 0.053
-
Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res. 2007 Jun 01; 67(11):5285-92.
Score: 0.016
-
Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions. Surgery. 2003 May; 133(5):568-79.
Score: 0.012